TrialJournal of gastroenterology2020

Effects of vedolizumab in Japanese patients with Crohn's disease: a prospective, multicenter, randomized, placebo-controlled Phase 3 trial with exploratory analyses.

Kenji Watanabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.